Stéphane Bancel, AP Images
August 10, 2021 08:58 AM EDTUpdated August 13, 03:59 PM
Bioregnum
Pharma

Mod­er­na soars in­to the ranks of the world's top phar­ma play­ers, now worth 3 Re­gen­erons

As we got start­ed this morn­ing, there was quite a bit of in­ter­est in see­ing if Mod­er­na could break the $200 bil­lion mark to­day on …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Sage sues Bio­gen days af­ter $469M buy­out of­fer

FDA ap­proves As­traZeneca and Dai­ichi Sankyo’s ADC for breast can­cer de­spite lack of sur­vival ben­e­fit

Ozem­pic makes list for next round of Medicare drug price ne­go­ti­a­tions

An­oth­er US biotech emerges with drug can­di­date from Chi­na-based Keymed

No­vo claims high-dose Phase 3 We­govy win but sales im­pact might be mut­ed

sponsored

Fu­el­ing More Break­throughs: Man­u­fac­tur­ing In­no­va­tion to Ex­pand Gene Ther­a­py’s Reach

A service from the Financial Times